Also found in: Dictionary, Thesaurus, Financial, Acronyms, Idioms, Encyclopedia, Wikipedia.


1. pertaining to a genus.
2. nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.


1. Relating to or denoting a genus.
2. General.
3. Characteristic or distinctive.
[L. genus (gener-), birth]
Farlex Partner Medical Dictionary © Farlex 2012


1. Biology Of or relating to a genus.
a. Relating to or being a product that is sold or distributed without any brand name or without a widely known brand name, especially as a discount alternative to a name-brand product: generic soap.
b. Relating to or being the official nonproprietary name of a drug, under which it is licensed and identified by the manufacturer.
A product or substance sold under or identified by a generic name.

ge·ner′i·cal·ly adv.
gen′e·ric′i·ty (jĕn′ə-rĭs′ĭ-tē), ge·ner·ic·ness n.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


Referring to the name assigned by the United States Adopted Name Council (USAN) once a compound has demonstrated some therapeutic efficacy, and has been recognised as the drug’s official name.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.


1. Relating to or denoting a genus.
2. General.
3. Characteristic or distinctive.
[L. genus (gener-), birth]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012


of or belonging to a genus.
Collins Dictionary of Biology, 3rd ed. © W. G. Hale, V. A. Saunders, J. P. Margham 2005

Patient discussion about generic

Q. When will a generic brand of insulin be available? The cost of insulin seems to be way too high... And with the ever rising population of diabetics, you'd think some other companies would jump unto the bandwagon with a cheaper insulin... what's up with that?

A. Unfortunately, as long as Eli Lilly has an effective monopoly on the American market and docs continue to perscribe the latest "flavor" of insulin, the situation is unlikely to change. Personally, I refuse to use Lilly's products (use Novo Nordisk insulin instead) and am still using the regular and NPH I was using 20 years ago... Also, because Type I diabetes tends to affect children, parents are naturally always seeking the next new thing. Doesn't make for an environment conducive to cheaper alternatives, which is a real shame for us all.

More discussions about generic
This content is provided by iMedix and is subject to iMedix Terms. The Questions and Answers are not endorsed or recommended and are made available by patients, not doctors.
References in periodicals archive ?
The initial chapters of this report provide an orientation of Generic Pharmaceutical dealmaking.
First, it should be noted that legalized generics have been around in some form or other since 1888, when the American Pharmaceutical Association published the National Formulary to prevent counterfeiting of branded products.
When asked how prices would be decreased, Mr Amanullah said over the years a number of pharmaceutical companies selling generic medicines had obtained permission to sell drugs at higher rates.
But generics are only cheaper because the manufacturers did not incur research and development expenses.
Hence, we would like to conclude that in our study we found that the prescribers had a fair knowledge regarding the safety, efficacy, and cost of generic medicines.
Doctors should do very much care after recognizing the patient's wealth condition they should depend upon a generic medicine but they feel proud to write a costly medicine for the patient to precure their visiting fee.
Based on distribution channel type, the global branded generics market is segmented into the following:
'I worked for an originator company for 20-odd years and one of our messages was this: if your kid had meningitis, would you use generics? It's the fear factor, and prejudices many doctors against generics which the patient obviously follows.'
The health agency had also said that generic drugs had become cheaper by more than 50 percent compared to branded counterparts and the market share of generic medicine had expanded to 60 percent since the passage of the generics law.
Q: Where do you see the opportunities and challenges for the generics industry while consistency evaluation is being made of generic drugs?
While people may be uncertain about using generic drugs initially, research has shown that they are more likely to adhere to treatment when prescribed more affordable generic drugs.

Full browser ?